We stay at the peak of our game by putting our knowledge to work. We actively drive an internal portfolio of socially conscious products, bringing innovation to areas of significant need. Companies interested in licensing or co-development are welcome to inquire.
OphthalmicsMacular Degeneration >> |
AMD is the leading cause of blindness in those over 60. While newly introduced therapies have over a 90% success rate, the majority of patients delay starting their treatment by more than 6 months, causing irreversible vision loss. We are addressing the leading unmet need in this market through a combination of patient research and tool development. Open Innovators led two research studies in 2008/2009 to better understand patient behavior and presentation delays, one of them sponsored by the leading bio-technology company in the AMD field. We also are working under National Eye Institute grants together with Johns Hopkins University in a parallel line of research to develop a novel program of home monitoring tools (KeepSight) for patient use. With FDA registration planned in 2010, in market trials are now underway. |
OphthalmicsDiabetic Retinopathy >> |
DR is the leading cause of blindness in those 20 to 60 years old. With over a 90% success rate in current treatments, the number one unmet medical need is focused on late presentation. Our interactive patient outreach program (I-Pop) use the principles of behavioral psychology in a game format to modify patient behavior and improve the likelihood of timely presentation and adherence with routine exam schedules. |
| Orthopedics >> |
Our interest in orthopedics is in the application of Universal Design. The principles of universal design are centered around the ability of products to provide advantage across a broad spectrum of users. Our research in the orthopedics area is on consumer & kitchen wares that enable people challenged with reduced limb strength to be self-sufficient. Through Universal Design, our goal is to take these appliances into a design category than anyone would find fashionable and desirable for their home and lifestyle. |
| Energy >> |
One can’t be active in today’s business climate without some element of clean and green in the portfolio. Our interests in the energy arena focus on technologies that will become necessary to support the commercialization of future proposed energy solutions. The invention of the i-phone created a market for .mobi applications; what will the creation of future energy technologies such as biomass, tar-sand exploitation and cyano-bacteria lead to? |
| Conflict Resolution >> |
When you bring teams of people together for over a decade and see the power of collective thought, it is hard not too see that each one of us can make a difference. Our program in conflict resolution is centered around a ten year goal to use open source web technology as a vehicle to improve inter-cultural understanding of the language and behaviors of conflict escalation and resolution. While this is much more low-tech than mapping the human genome, over the coming years, we will continue to map the elemental building blocks associated with conflict its resolution. |
Associates
Mark Roser - Founder
With ten years in corporate R&D and marketing and 12 years of consulting with companies such as Pfizer, Eaton Corporation, Cummins, Crayola, Cadbury/Adams, Bic, Warner Lambert, Printpack and others – Mark transforms his in-depth understanding of innovation, product development, IP and licensing into action. He is passionate about listening to customers and bringing new ideas to life. He has the unusual capability to look at old problems and discover new solutions.
Ned O'Donovan
With 20+ years experience in industries ranging from high-tech, to pharmaceutical, to aerospace, Ned is the consummate new product development specialist. Ned has been certified by both the PMI and PDMA and lectures on the topic of new product development at Rensselaer Polytechnic. He is well versed in both innovation strategy as well as hands-on execution. Ned will not rest until his programs succeed.
Eric Spencer
Eric brings ideas to life. As a fast visual prototyper, Eric can transform written words into fully illustrated concepts that enable a team to elevate their thinking and accelerate concept development. But Eric is not just about drawing, he has the ability to look at problems from many disparate points of view, understand new opportunities and illuminate new solutions.
Sheryl Torr-Brown, PhD
With 20+ years experience in a variety of health disciplines, Sheryl is keenly aware of the intricacies of bringing new therapies to market. As an executive within Pfizer’s R&D group, Sheryl led the way for improvements in knowledge management and innovations in health technology. Currently, she focuses on translational roles to help health companies understand the patient and vice-versa.
Ted Nunes
The ability to stay ahead of the curve requires a keen understanding of current market trends and customer insights to predict and define best-in-class. This is why we like Ted. He brings together the art and science of marketing to produce actionable specifications that provide real direction and metrics for 'next level' success. With an eye for detail, Ted breaks down often ambiguous situations into the tangible elements that drive business value.
Jeremie Spitzer
Jeremie makes things happen and brings new ideas to life. He has developed, managed and launched new products and services in the online game, online accessibility and the clean tech sectors. Jeremie cofounded All inPlay, the world leader in accessible online games. He’s passionate about efficient processes, measuring results, and solving unique problems.
Featured Advisor
Open Innovators has been blessed to work with a wide variety of experts in innovation who have led the field and made a lasting impact on how we, as consultants, view the world. Having worked with chief technology officers, heads of R&D, chief innovation officers, heads of portfolio management and leaders of IP, we are humbly appreciative of the many opportunities they have given us to contribute to their organizations, and we value the guidance that they have shared with us.
Each quarter, we will feature one of our advisors as a way to show our appreciation.
This quarter’s featured advisor:
Robert “Bob” Moore - principal at MResult
We worked with Bob when he was Executive Director of Project and Portfolio Management at Pfizer’s Global R&D headquarters. Bob makes a lasting impression on the people he meets, especially those fortunate enough to work with him. Working with Bob, one learns the art of listening, the art of skillfully re-directing negative comments into positive challenges, the craft of bringing teams forward to a result, the ability to distill complex situations into clear summaries. You can now find Bob at MResult – a consultancy focused on novel enterprise project and portfolio management solutions.